(CYTK) Cytokinetics - Performance -43.3% in 12m
Compare CYTK with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
41.33%
#17 in Group
Rel. Strength
14.67%
#6519 in Universe
Total Return 12m
-43.29%
#89 in Group
Total Return 5y
223.03%
#17 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -0.42
23th Percentile in Group
FCF Yield -8.48%
(unknown) Percentile in Group
12m Total Return: CYTK (-43.3%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: CYTK vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CYTK
Total Return (including Dividends) | CYTK | XBI | S&P 500 |
---|---|---|---|
1 Month | -6.16% | -5.85% | -3.01% |
3 Months | -17.74% | -11.95% | -3.15% |
12 Months | -43.29% | -11.00% | 10.19% |
5 Years | 223.03% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | CYTK | XBI | S&P 500 |
1 Month | -39.1% | -59.8% | -5.5% |
3 Months | -63.4% | -70.5% | -58.4% |
12 Months | -83.0% | -6.9% | 84.1% |
5 Years | 80.3% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #77 | -0.33% | -3.25% |
3 Month | #73 | -6.58% | -15.1% |
12 Month | #88 | -36.3% | -48.5% |
5 Years | #16 | 221% | 40.9% |
FAQs
Does CYTK Cytokinetics outperforms the market?
No,
over the last 12 months CYTK made -43.29%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months CYTK made -17.74%, while XBI made -11.95%.
Over the last 3 months CYTK made -17.74%, while XBI made -11.95%.
Performance Comparison CYTK vs Indeces and Sectors
CYTK vs. Indices CYTK is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -7.03% | -3.15% | -23.4% | -53.5% |
US NASDAQ 100 | QQQ | -6.05% | -2.10% | -22.6% | -51.9% |
US Dow Jones Industrial 30 | DIA | -7.23% | -4.02% | -24.3% | -52.8% |
German DAX 40 | DAX | -5.73% | -2.78% | -40.2% | -65.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | -6.74% | -6.39% | -8.13% | -52.4% |
Hongkong Hang Seng | HSI | -9.0% | -8.93% | -14.1% | -60.6% |
India NIFTY 50 | INDA | -8.06% | -14.0% | -13.0% | -44.0% |
Brasil Bovespa | EWZ | -7.14% | -14.5% | -15.4% | -31.6% |
CYTK vs. Sectors CYTK is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -5.49% | -2.35% | -31.5% | -62.5% |
Consumer Discretionary | XLY | -7.79% | -2.33% | -26.7% | -57.4% |
Consumer Staples | XLP | -9.82% | -4.32% | -24.2% | -54.3% |
Energy | XLE | -8.12% | -14.2% | -28.9% | -44.1% |
Financial | XLF | -7.51% | -3.46% | -35.5% | -65.5% |
Health Care | XLV | -7.45% | -3.0% | -18.7% | -45.0% |
Industrial | XLI | -7.34% | -5.47% | -22.7% | -51.8% |
Materials | XLB | -8.13% | -6.67% | -15.3% | -39.4% |
Real Estate | XLRE | -9.07% | -3.47% | -20.2% | -56.7% |
Technology | XLK | -5.90% | -2.15% | -18.2% | -45.3% |
Utilities | XLU | -10.3% | -6.98% | -22.5% | -68.5% |
Aerospace & Defense | XAR | -6.43% | -7.44% | -27.3% | -64.2% |
Biotech | XBI | -2.47% | -0.31% | -5.66% | -32.3% |
Homebuilder | XHB | -7.53% | -6.31% | -3.98% | -35.6% |
Retail | XRT | -9.33% | -5.66% | -19.3% | -38.5% |